𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients

✍ Scribed by Christian Walter; Bilal Al-Nawas; Andreas du Bois; Laura Buch; Philipp Harter; Knut A. Grötz

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
123 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence and risk factors of bisphospho
Incidence and risk factors of bisphosphonate-associated osteonecrosis of the jaws
✍ Matthew R. Stumpe; Rakesh K. Chandra; Furhan Yunus; Sandeep Samant 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

## Abstract ## Background Intravenous bisphosphonate therapy has been used for treatment of benign and malignant bone diseases and has been linked to osteonecrosis of the jaws. ## Methods Records of 638 patients treated with intravenous bisphosphonates were reviewed. Drug used, number of infusio

Bisphosphonate-associated osteonecrosis
Bisphosphonate-associated osteonecrosis of the jaws: The limits of a conservative approach
✍ Giancarlo Tirelli; Matteo Biasotto; Silvia Chiandussi; Franca Dore; Elena De Nar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 2 views

## Abstract ## Background. An increasing number of cases of osteonecrosis of the jaws (ONJ) in patients treated with bisphosphonates has been reported in the literature. ONJ significantly affects the patients' quality of life and its management is still extremely difficult. ## Methods. A woman w

Patients with bisphosphonates-associated
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells
✍ A Allegra; G Oteri; E Nastro; A Alonci; G Bellomo; V Del Fabro; E Quartarone; C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB 👁 1 views

## Abstract Osteonecrosis of the jaws (ONJ) associated with the use of bisphosphonates is a newly described entity. To elucidate the mechanism leading to ONJ and to test the hypothesis that in patients with ONJ the bisphosphonates may interfere with endothelial cell proliferation, using flow cytome

Bisphosphonate-related osteonecrosis of
Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: A belgian case series
✍ Sven Saussez; Rokneddine Javadian; Chloé Hupin; Michèle Magremanne; Gilbert Chan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 1 views

## Abstract ## Objectives: Bisphosphonate‐related osteonecrosis of the jaw (BROJ) is a serious oral complication of bisphosphonate (BP) treatment involving the exposure of necrotic maxillary or mandibular bone. Our purpose is to describe the clinical presentation of 34 cases of BROJ and to identif

Increased prevalence of bisphosphonate-r
Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats
✍ Akishige Hokugo; Russell Christensen; Evelyn M Chung; Eric C Sung; Alan L Felsen 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 409 KB

Necrotic bone exposure in the oral cavity has recently been reported in patients treated with nitrogen-containing bisphosphonates as part of their therapeutic regimen for multiple myeloma or metastatic cancers to bone. It has been postulated that systemic conditions associated with cancer patients c